🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT03830879
Recruiting Observational

Shenzhen Birth Cohort Study

NCT03830879 · tracked via the Priya Life Science China tracker
Sponsor
Sun Yat-sen University
Phase
Observational
Started
2018-03-06
Last updated
2019-02-05

Condition(s) studied

Pregnancy ComplicationsGestational DiabetesObstetric Labor ComplicationsNeurodevelopmental DisordersChildhood Obesity

Investigational drug(s) / intervention(s)

No intervention

No intervention: This cohort study have any no intervention.

Study summary

The Shenzhen Birth Cohort Study was set up to investigate the effect of early life environmental exposures on short- and long-term health consequences in Shenzhen, China.

Eligibility

Sex
ALL
Min age
15 Years
Max age
49 Years
Healthy volunteers
Accepted
Inclusion Criteria: * 1\. Pregnant women plan to delivery and participate in child care in our hospital; 2. Pregnant women plan to reside in Shenzhen for at least 7 years; 3. Pregnant women who show interest in the study and agree to provide informed consent; 4. Gestational weeks are less than 20 weeks.Those who will agree that their neonatal will be included in the study and be followed up regularly in our child health clinic until an age of 7 years. Exclusion Criteria: * Pregnant women who have been pregnant for more than 20 weeks; refuse to participate; unable to guarantee delivery in our hospital or can't participate in child care in our hospital; mentally incapacitated and need guardians; or be unwilling to sign informed consent.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
RuiGao Shenzhen Guangdong Recruiting

More Sun Yat-sen University trials in China

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT03830879 on ClinicalTrials.gov ↗ ← All trials in China